Yield10 Bioscience Completes Harvest Of A Majority Of The 2023 Winter And Spring Camelina Grain Grown Under Contract, Generating Revenue From Biofuel Production
Portfolio Pulse from Benzinga Newsdesk
Yield10 Bioscience, Inc. (NASDAQ:YTEN) has completed the harvest of a majority of the winter and spring Camelina grain produced under grower contracts in 2022/2023. The harvested grain is being delivered to an offtake partner for biofuel production, marking the establishment of the company's 'Camelina Seed Genetics to Biofuel' platform. This has allowed Yield10 to start generating revenue from Camelina grain delivery for the production of feedstock oil for sustainable transportation fuels. The company expects the revenue stream from sales of Camelina grain to be a significant contributor to its financial profile in the future.
October 03, 2023 | 12:34 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Yield10 Bioscience has started generating revenue from its 'Camelina Seed Genetics to Biofuel' platform. This new revenue stream is expected to significantly contribute to the company's financial profile in the future.
The completion of the harvest and the start of revenue generation from the 'Camelina Seed Genetics to Biofuel' platform is a significant milestone for Yield10 Bioscience. This new revenue stream, which is expected to be a key contributor to the company's financial profile in the future, could positively impact the company's stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100